Cellectis SA (CLLS)
2.65
+0.10
(+3.92%)
USD |
NASDAQ |
Apr 22, 16:00
2.65
0.00 (0.00%)
After-Hours: 20:00
Cellectis Price to Book Value: 2.492 for April 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 22, 2024 | 2.492 |
April 19, 2024 | 2.398 |
April 18, 2024 | 2.323 |
April 17, 2024 | 2.313 |
April 16, 2024 | 2.342 |
April 15, 2024 | 2.454 |
April 12, 2024 | 2.530 |
April 11, 2024 | 2.633 |
April 10, 2024 | 2.624 |
April 09, 2024 | 2.586 |
April 08, 2024 | 2.530 |
April 05, 2024 | 2.520 |
April 04, 2024 | 2.586 |
April 03, 2024 | 2.624 |
April 02, 2024 | 2.492 |
April 01, 2024 | 2.388 |
March 28, 2024 | 2.492 |
March 27, 2024 | 2.511 |
March 26, 2024 | 2.417 |
March 25, 2024 | 2.426 |
March 22, 2024 | 2.351 |
March 21, 2024 | 2.379 |
March 20, 2024 | 2.304 |
March 19, 2024 | 2.266 |
March 18, 2024 | 2.342 |
Date | Value |
---|---|
March 15, 2024 | 2.388 |
March 14, 2024 | 2.379 |
March 13, 2024 | 2.407 |
March 12, 2024 | 2.464 |
March 11, 2024 | 2.285 |
March 08, 2024 | 2.436 |
March 07, 2024 | 2.360 |
March 06, 2024 | 2.370 |
March 05, 2024 | 2.332 |
March 04, 2024 | 2.445 |
March 01, 2024 | 2.492 |
February 29, 2024 | 2.426 |
February 28, 2024 | 2.398 |
February 27, 2024 | 2.558 |
February 26, 2024 | 2.558 |
February 23, 2024 | 2.661 |
February 22, 2024 | 2.736 |
February 21, 2024 | 2.690 |
February 20, 2024 | 2.567 |
February 16, 2024 | 2.718 |
February 15, 2024 | 2.680 |
February 14, 2024 | 2.680 |
February 13, 2024 | 2.624 |
February 12, 2024 | 2.849 |
February 09, 2024 | 2.878 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5691
Minimum
Jun 16 2022
5.012
Maximum
Jan 19 2021
1.851
Average
1.740
Median
Nov 25 2019
Price to Book Value Benchmarks
DBV Technologies SA | 0.9069 |
Biophytis SA | -- |
Genfit SA | 2.430 |
Edap TMS SA | 4.237 |
Biodexa Pharmaceuticals Plc | 0.5629 |
Price to Book Value Related Metrics
PS Ratio | 8.382 |
Price | 2.65 |
Earnings Yield | -63.02% |
Market Cap | 189.70M |